Pattarawat Thantiworsit

Mr. Pattarawat Thantiworsit

Chulalongkorn hospital

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JMJulie L. Mitchell
Julie L. Mitchell
JPJustin Pollara
Justin Pollara
KDKenneth Dietze
Kenneth Dietze
RER. Whitney Edwards
R. Whitney Edwards
JNJunsuke Nohara
Junsuke Nohara
LTLydie Trautmann
Lydie Trautmann
Early initiation of antiretroviral therapy (ART) in acute HIV infection (AHI) is effective at limiting seeding of the HIV viral reservoir, but little is known about how the resultant decreased antigen load affects long-term Ab development after ART. We report here that Env-specific plasma antibody (Ab) levels and Ab-dependent cellular cytotoxicity (ADCC) increased during the first 24 weeks of ART and correlated with Ab levels persisting after 48 weeks of ART. Participants treated in AHI stage 1 had lower Env-specific Ab levels and ADCC activity on ART than did those treated later. Importantly, participants who initiated ART after peak viremia in AHI developed elevated cross-clade ADCC responses that were detectable 1 year after ART initiation, even though clinically undetectable viremia was reached by 24 weeks. These data suggest that there is more germinal center (GC) activity in the later stages of AHI and that Ab development continues in the absence of detectable viremia during the first year of suppressive ART. The development of therapeutic interventions that can enhance earlier development of GCs in AHI and Abs after ART initiation could provide important protection against the viral reservoir that is seeded in individuals treated early in the disease.

8 January 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Palittiya SintusekPalittiya Sintusek
Palittiya Sintusek
SBSupranee Buranapraditkun
Supranee Buranapraditkun
PWPiyaporn Wanawongsawad
Piyaporn Wanawongsawad
NPNawarat Posuwan
Nawarat Posuwan
PTPattarawat Thantiworsit
Pattarawat Thantiworsit
YPYong Poovorawan
Yong Poovorawan
A high prevalence of hepatitis B (HepB) antibody loss after liver transplantation (LT) and de novo HepB infection (DNH) was documented, hence revaccination to prevent DNH is crucial. This study aimed to compare the safety and immunogenicity of two HepB vaccine regimens in liver-transplanted children. Liver-transplanted children who were previously immunised but showed HepB surface antibodies (anti-HBs) ≤ 100 mIU/mL were randomised to receive a standard three-dose (SD) and double three-dose (DD) vaccine intramuscularly in months 0–1–6. Anti-HBs and T-cell-specific response to the HepB antigen were assessed. A total of 61 children (54.1% male, aged 1.32 ± 1.02 years) completed the study without any serious adverse reaction. The seroprotective rate was 69.6% vs. 60% (p = 0.368) and 91.3% vs. 85% (p = 0.431) in SD and DD after the first and third 3-dose vaccinations, respectively. The geometric mean titre (95% confidence interval) of anti-HBs in SD and DD were 443.33 (200.75–979.07) vs. 446.17 (155.58–1279.50) mIU/mL, respectively, at completion. Numbers of interferon-γ-secreting cells were higher in hyporesponders/responders than in nonresponders (p = 0.003). The significant factors for the immunologic response to HepB vaccination were anti-HB levels prevaccination, tacrolimus trough levels, and time from LT to revaccination. SD and DD had comparative immunogenicity and were safe for liver-transplanted children who were previously immunised.

26 May 2025 in Journal of Virus Eradication
Verified
Journal Article
Open access
SBSupranee Buranapraditkun
Supranee Buranapraditkun
JMJulie L. Mitchell
Julie L. Mitchell
HTHiroshi Takata
Hiroshi Takata
EKEugene Kroon
Eugene Kroon
SPSuteeraporn Pinyakorn
Suteeraporn Pinyakorn
LTLydie Trautmann
Lydie Trautmann
Innate, cellular and humoral immunity in acute HIV infection (AHI) play crucial roles in dictating immunological and pathological outcomes. However, understanding immune cell dynamics in different compartments during AHI is limited. In this study, we characterized immune cells from matched blood and lymph node samples in the RV254 Thai AHI cohort, the RV304 Thai chronic HIV infection cohort, and HIV-negative individuals, using flow cytometry. Our results showed a significant loss of the CD4:CD8 ratio in both PBMCs and LNMCs during AHI. Similarly, we observed increased immune activation of CD4+ and CD8+ T cells in both blood and lymph node compartments during AHI. In contrast, we found no increase in T follicular helper cells (Tfh) and a lack of association between circulating Tfh and lymph node Tfh during AHI. Furthermore, early B cell depletion, particularly in resting memory B cells, was observed in blood but not in lymph nodes during AHI. Additionally, during AHI, plasmacytoid dendritic cell activation was increased in lymph nodes but not in blood. These findings suggest that certain immune cell phenotypes and dynamics are unique in lymph nodes compared to blood during AHI. Understanding the immune cell alteration in these compartments during AHI may help define the mechanisms leading to lack of immune control in natural HIV infection.